发明名称 IMIDAZOLONE DERIVATIVE
摘要 <P>PROBLEM TO BE SOLVED: To provide a compound that can prevent endothelial function disorders, can maintain the vascular function in a healthy state, allows oral ingestion, is safe for continuous long term ingestion, and exhibits eNOS (endothelial nitric oxide synthase) activity. <P>SOLUTION: There are disclosed an imidazolone derivative represented by formula (1) [in the formula, R<SB POS="POST">1</SB>represents a hydrogen atom or a 1-10C alkyl group; R<SB POS="POST">2</SB>represents a 1-10C alkyl group comprising at least one hydroxy group; and R<SB POS="POST">3</SB>represents a 1-10C alkyl group that may contain an amino group and/or a carboxy group, provided that R<SB POS="POST">2</SB>is not a 2,3,4-trihydroxybutyl group if R<SB POS="POST">1</SB>is a hydrogen atom and R<SB POS="POST">3</SB>is -(CH<SB POS="POST">2</SB>)<SB POS="POST">3</SB>-CH(NH<SB POS="POST">2</SB>)CO<SB POS="POST">2</SB>H], and a salt thereof. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2011231022(A) 申请公布日期 2011.11.17
申请号 JP20100100216 申请日期 2010.04.23
申请人 AJINOMOTO CO INC 发明人 YAMADA KAZUHIRO;KOYAMA NAOTO;NOMURA KENZO;OTA MASAFUMI
分类号 C07D233/88;A61K31/4168;A61P3/06;A61P3/10;A61P7/06;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P13/12;A61P15/10;A61P17/02;A61P17/14;A61P21/02;A61P25/28;A61P43/00 主分类号 C07D233/88
代理机构 代理人
主权项
地址